EGFR and non-small cell lung carcinoma: Among patients with non‐squamous NSCLC, the most commonly used methods of detection for EGFR mutation and ALK rearrangement were ARMS (933/1025, 91.0%) and IHC targeting D5F3 (637/1025, 62.1%), respectively.